Model DetailsLiver hepatocellular adenoma
Model Name |
Liver hepatocellular adenoma | Strain |
(C57BL/6N x C3H/HeN)F1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
liver, hepatocellular adenoma • hepatocellular neoplasm • hepatocellular adenoma • liver adenoma • liver hepatocellular adenoma • liver hyperplastic nodule (HN) |
Strain Synonyms |
BCF1 • B6C3F1 • C57BL/6NxC3H/HeN F1 • B6C3F1 • (C57BL/6N X C3H/HeN)F1 |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Liver | Male |
14.6% (31 of 213 mice) |
120 weeks |
|
Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
| Liver | Female |
6.1% (13 of 213 mice) |
120 weeks |
|
Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
| Liver | Male |
26.2% (64 of 244 mice) |
2 years |
|
Tamano S, Toxicol Pathol 1988;16(3):321-6 |
| Liver | Female |
5.7% (14 of 246 mice) |
2 years |
|
Tamano S, Toxicol Pathol 1988;16(3):321-6 |
| Liver | Female |
7.1% (1 of 14 mice) |
18 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Liver | Female |
7.7% (1 of 13 mice) |
24 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Liver | Female |
6.7% (1 of 15 mice) |
30 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Liver | Female |
35.7% (5 of 14 mice) |
36 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Liver | Female |
6.25% (2 of 32 mice) |
24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Liver | Female |
4.1% (3 of 73 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Liver | Female |
29.4% (5 of 17 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Liver | Male |
14.3% (2 of 14 mice) |
18 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Liver | Male |
6.7% (1 of 15 mice) |
24 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Liver | Male |
26.7% (4 of 15 mice) |
30 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Liver | Male |
46.7% (7 of 15 mice) |
36 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Liver | Male |
37.5% (3 of 8 mice) |
18 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Liver | Male |
19.1% (9 of 47 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Liver | Male |
23.5% (8 of 34 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Liver | Male |
42.9% (3 of 7 mice) |
42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Liver | Male |
12.5% (1 of 8 mice) |
24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Liver | Male |
4.8% (1 of 21 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Liver | Male |
31.25% (5 of 16 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Liver | Male |
50% (4 of 8 mice) |
42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Liver | Male |
7.9% (201 of 2543 mice) |
94-114 weeks |
|
Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
| Liver | Female |
1.59% (40 of 2522 mice) |
94-114 weeks |
|
Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
| Liver | Mixed Population |
4.76% (241 of 5065 mice) |
94-114 weeks |
|
Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |